🔎 Trials Near Me

Dachaigh › HIV › Texas

Sgrùdaidhean clionaigeach HIV ann an Texas

Tha 23 sgrùdaidhean airson HIV a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

  • Abounding Prosperity Inc., Dallas
  • Prism Health, Dallas
  • UT Health, Houston
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07473778

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  • GSK Investigational Site, Austin
  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Dallas
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07650916

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV

  • Baylor College of Medicine, Houston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06274632

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

  • Saint Hope Foundation, Inc. ( Site 1504), Bellaire
  • Prism Health North Texas, Oak Cliff Health Center ( Site 1514), Dallas
  • Texas Center for Infectious Disease Associates ( Site 1502), Fort Worth
  • agus 1 a bharrachd
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07266831

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

  • 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
A’ fastadhÌre 1/2
48 Hours · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT02140255

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT02479698

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

  • The Crofoot Research Center, Houston
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT07698600

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

  • University of Texas M.D. Anderson Cancer Center, Houston
A’ fastadh
Aoisean 45 gu 80 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT04949464

Positive Peers Intervention Clinical Trial

  • Thomas Street Clinic, Houston
A’ fastadh
Aoisean 13 gu 34 · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06388109

Screen2Prevent (S2P)

  • Baylor College of Medicine, Houston
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 14 gu 24 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07728123

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  • North Texas Infectious Diseases Consultants, P.A., Dallas
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT07682961

First Time in Human Study of Long Acting VH4524184 Formulations

  • GSK Investigational Site, San Antonio
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06310551

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

  • UT Health Houston, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07143968

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  • GSK Investigational Site, Bellaire
  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Houston
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT07202546

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

  • Houston Methodist Research Institute, Houston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT06263426

Menopausal HT for Women Living With HIV (HoT)

  • Houston AIDS Research Team CRS (31473), Houston
A’ fastadhÌre 4
Aoisean 40 gu 60 · Banairean · Air ùrachadh 22 Cèit 2026 · NCT06856174

Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness

  • The University of Texas Health Science Center at Houston, Houston
A’ fastadh
Aoisean 18 gu 25 · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT06074354

HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients

  • UT Southwestern Medical Center, Dallas
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Faoi 2026 · NCT06659952

The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services

  • UT Southwestern Medical Center, Dallas
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 15 Faoi 2026 · NCT07292792

A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

  • GSK Investigational Site, Austin
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 18 Dùbh 2025 · NCT05418868

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

  • UT Health Houston, Houston
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 17 Dùbh 2025 · NCT05488431

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

  • GSK Investigational Site, Austin
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 29 Dàmh 2025 · NCT06724640

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
A’ fastadhÌre 1/2
Aoisean 6 gu 12 · Gach gnè · Air ùrachadh 19 Sult 2024 · NCT05674656

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.